Tag: Cancer: Pancreatic
Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity
Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor
Most Patients With Stage I PDAC Are Upstaged on Histopathology
More than 70 percent with stage I pancreatic ductal adenocarcinoma and about 30 percent with stage II PDAC upstaged after surgery
AI-Assisted Model Improves Diagnosis of Solid Lesions in Pancreas
Model integrating clinical information and endoscopic ultrasonographic images enhances diagnostic accuracy of novice endoscopists
Subclassification Can Tailor Surveillance for Pancreatic Adenocarcinoma
High-risk individuals were classified into three groups based on familial pancreatic cancer and a pathogenic germline variant
AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
Signature resulting from combining cell-free-miRNAs, exosomal-miRNAs distinguished patients with PDAC from healthy donors
No-Drain Policy Noninferior for Major Morbidity in Distal Pancreatectomy
Grade B or C postoperative pancreatic fistula occurred in significantly fewer patients in the no-drain versus drain groups
FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy
Opioid-Free Discharge Feasible After Pancreatectomy
In a recent study, there was an increase in the percentage of patients discharged opioid-free
Lorazepam Has Negative Impact on Survival in Pancreatic Cancer
Alprazolam reduced IL-6 in human pancreatic cancer-associated fibroblasts and was associated with improved progression-free survival